Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive, Peripheral

Explore clinical trials studying Neuroectodermal Tumors, Primitive, Peripheral. Study availability and eligibility vary by location and protocol.

501 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive, Peripheral trial results

Completed

N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma

NCT00646230

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

NCT00026312

Conditions
Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neoplasms, +13 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 197 locations
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

NCT05199584

Conditions
Adenoma, Adenoma, Islet Cell, Brain Diseases, +52 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Zion, Illinois, United States
View all 16 locations
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

NCT04238819

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • The Regents of the University of California - Los Angeles (UCLA Pediatrics) Los Angeles, California, United States
  • Kaiser Permanente Oakland Oakland, California, United States
  • Kaiser Permanente Roseville Roseville, California, United States
View all 25 locations
View Trial Details
Completed

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

NCT02909777

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumor, +22 more
Locations
  • University of California, San Francisco, Benioff Children's Hospital San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's, Baylor College of Medicine Houston, Texas, United States
View Trial Details
Completed

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

NCT01175356

Conditions
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, +13 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 25 locations
View Trial Details
Completed

Molecular-Guided Therapy for Childhood Cancer

NCT02162732

Conditions
Adenocarcinoma, Brain Diseases, Brain Neoplasms, +65 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View all 19 locations
View Trial Details

Related conditions